September 07, 2025 a 07:43 pm

GEHC: Fundamental Ratio Analysis - GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc.

GE HealthCare Technologies operates across diverse segments, offering imaging services, ultrasounds, patient care solutions, and pharmaceutical diagnostics. Incorporated in 2022, the company rapidly established its presence globally, driven by innovative healthcare solutions. With a focus on expanding its market share, the company's financial health merits a closer look.

Fundamentals Rating

GEHC displays a solid overall performance with particular strengths in return on equity and discounted cash flow metrics.

Category Score Visual
Discounted Cash Flow 4
Return on Equity 5
Return on Assets 4
Debt to Equity 1
Price to Earnings 2
Price to Book 2

Historical Rating

The historical scores provide insights into the company's performance trajectory, indicating consistency in some areas and improvement in others.

Date Overall DCF ROE ROA D/E P/E P/B
2025-09-05 3 4 5 4 1 2 2
Previous Date 0 4 5 4 1 2 2

Analyst Price Targets

Analysts are optimistic, with a consensus pointing towards a buy, supported by a potential upside in the stock's target price range.

High Low Median Consensus
$95 $73 $84 $84
Stock Price Chart showing historic and target prices

Analyst Sentiment

The consensus is overwhelmingly positive, with no sell recommendations and a strong inclination towards buy ratings.

Recommendation Count Visual
Strong Buy 0
Buy 12
Hold 4
Sell 0
Strong Sell 0

Conclusion

GE HealthCare Technologies Inc. manifests robustness across multiple financial metrics, making it an attractive consideration for investors. With a commendable return on equity and solid discounted cash flows, its fundamental strengths are evident. Analyst sentiment reinforces optimism, projecting a favorable outlook. However, potential investors should be mindful of the company's debt-to-equity ratio, which suggests leverage usage. Overall, GEHC's strategic positioning in the global healthcare technology landscape offers promising growth opportunities.